榮盛石化(002493.SZ):浙石化年產26萬噸聚碳酸酯裝置順利投產
格隆匯9月26日丨榮盛石化(002493.SZ)公佈,公司控股子公司浙江石油化工有限公司(簡稱“浙石化”)在舟山綠色石化基地投資建設的“4000萬噸/年煉化一體化項目(二期)”年產26萬噸聚碳酸酯裝置於近期投料成功,目前已順利產出合格產品。
聚碳酸酯是重要的工程塑料之一,具備優異的物理和光學性能,廣泛應用於下游的多個領域。該裝置的順利投產使得公司的聚碳酸酯年產能增加至52萬噸/年,目前位於全國第一,全球前列,並將有助於提高國內工程塑料的自給率,確保國內相關產業供應鏈安全。
公司表示,該裝置的產線規模大,各項工藝技術指標達到國際先進水平。公司將繼續以安全生產為首要任務,優化工藝參數,提升運行水平,以實際行動踐行雙碳減排,持續推動公司高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.